Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| American Well CorpAMWL · Entity 2112 | Chief Financial Officer | October 01, 2026 | October 05, 2026 |
| Talkspace, Inc.TALK · Entity 22747 | President and COO | July 15, 2021 | October 20, 2021 |
| Teladoc Health, Inc.TDOC · Entity 1547 | Executive VP, COO and CFO | December 13, 2018 | December 17, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
American Well Corp
Report date October 01, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 223,906 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Sale · Disposed 4,282 · Balance 223,906 F1: The sales reported in this Form 4 were made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on October 1, 2026. The sales were effected through and automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on October 1, 2026. The sales were effected through and automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person.
Talkspace, Inc.
Report date July 15, 2021 · Filed October 20, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 788,967 |
Reported balance
After 2021-10-18 transaction · row 1
1 source rowRow 1 · 2021-10-18 · Grant · Acquired 247,500 · Balance 788,967 F1: Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Talkspace, Inc. common stock. The RSUs vest in 16 substantially equally installments on a quarterly basis, subject to the Reporting Person's continued service with the Company through each vesting date. |
| Employee Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $5.81 · Expires 2031-07-14 | Direct | 990,000 |
Reported balance
After 2021-07-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-07-15 · Grant · Acquired 990,000 · Balance 990,000 F2: The stock option vests in 16 substantially equally installments on a quarterly basis, subject to the Reporting Person's continued service with the Company through each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Talkspace, Inc. common stock. The RSUs vest in 16 substantially equally installments on a quarterly basis, subject to the Reporting Person's continued service with the Company through each vesting date.
F2: The stock option vests in 16 substantially equally installments on a quarterly basis, subject to the Reporting Person's continued service with the Company through each vesting date.
Teladoc Health, Inc.
Report date December 13, 2018 · Filed December 17, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,000 |
Ending reported balance
After 2018-12-13 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2018-12-13 · Exercise / conversion · Acquired 1,001 · Balance 3,658 Row 2 · 2018-12-13 · Exercise / conversion · Acquired 684 · Balance 4,342 Row 3 · 2018-12-13 · Exercise / conversion · Acquired 2,284 · Balance 6,626 Row 4 · 2018-12-13 · Exercise / conversion · Acquired 3,081 · Balance 9,707 Row 5 · 2018-12-13 · Exercise / conversion · Acquired 293 · Balance 10,000 |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.67 · Expires 2023-12-11 | Direct | 7,008 |
Reported balance
After 2018-12-13 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2018-12-13 · Exercise / conversion · Disposed 1,001 · Balance 7,008 F1: The option vests as to 25% of the shares on December 11, 2014. The remainder of the shares vest in 36 equal monthly installments thereafter. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.01 · Expires 2024-09-10 | Direct | 6,151 |
Reported balance
After 2018-12-13 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2018-12-13 · Exercise / conversion · Disposed 684 · Balance 6,151 F2: The option vests as to 25% of the shares on September 10, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.01 · Expires 2024-12-22 | Direct | 29,692 |
Reported balance
After 2018-12-13 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2018-12-13 · Exercise / conversion · Disposed 2,284 · Balance 29,692 F3: The option vests as to 25% of the shares on December 22, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.21 · Expires 2026-03-07 | Direct | 83,194 |
Reported balance
After 2018-12-13 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2018-12-13 · Exercise / conversion · Disposed 3,081 · Balance 83,194 F4: The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $22.30 · Expires 2027-03-03 | Direct | 102,352 |
Reported balance
After 2018-12-13 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2018-12-13 · Exercise / conversion · Disposed 293 · Balance 102,352 F5: The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests as to 25% of the shares on December 11, 2014. The remainder of the shares vest in 36 equal monthly installments thereafter.
F2: The option vests as to 25% of the shares on September 10, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter.
F3: The option vests as to 25% of the shares on December 22, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter.
F4: The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter.
F5: The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 5, 2026 21:28 UTC | American Well Corp AMWL · Entity 2112 | SaleClass A Common Stock | 4,282 | $13.00 | $55,666.00 |
DisclosureSEC source: 0001081343-26-000004 · ownership.xml · nonDerivative · entry 1 HIRSCHHORN MARK · CIK 0001081343 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 223,906 F1 · kind: The sales reported in this Form 4 were made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on October 1, 2026. The sales were effected through and automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 21:11 UTC | American Well Corp AMWL · Entity 2112 | SaleClass A Common Stock | 10,751 | $11.80 | $126,861.80 |
DisclosureSEC source: 0001193125-26-382079 · ownership.xml · nonDerivative · entry 1 HIRSCHHORN MARK · CIK 0001081343 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 228,188 F1 · kind: The sales reported in this Form 4 were made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on September 1, 2026. The sales were effected through and automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person. Read SEC document |
| July 01, 2026 Filed Jul 1, 2026 21:20 UTC | American Well Corp AMWL · Entity 2112 | SaleClass A Common Stock | 4,299 | $9.33 | $40,109.67 |
DisclosureSEC source: 0001193125-26-292835 · ownership.xml · nonDerivative · entry 1 HIRSCHHORN MARK · CIK 0001081343 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 238,939 F1 · kind: The sales reported in this Form 4 were made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on July 1, 2026. The sales were effected through and automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 21:01 UTC | American Well Corp AMWL · Entity 2112 | SaleClass A Common Stock | 10,761 | $9.74 | $104,812.14 |
DisclosureSEC source: 0001193125-26-255719 · ownership.xml · nonDerivative · entry 1 HIRSCHHORN MARK · CIK 0001081343 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 243,238 F1 · kind: The sales reported in this Form 4 were made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on June 1, 2026. The sales were effected through and automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 22:00 UTC | American Well Corp AMWL · Entity 2112 | GrantClass A Common Stock | 50,413 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-096838 · ownership.xml · nonDerivative · entry 1 HIRSCHHORN MARK · CIK 0001081343 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 253,999 F1 · kind: Represents a grant of restricted stock units ("RSUs"), which will vest in equal quarterly increments over a two (2) year period, beginning on the first calendar day of the month following the date that is three months following the grant date until such RSUs are fully vested on the first calendar day of the month following the 24 month anniversary of the grant date. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 23:02 UTC | American Well Corp AMWL · Entity 2112 | SaleClass A Common Stock | 10,796 | $5.24 | $56,571.04 |
DisclosureSEC source: 0001193125-26-088968 · ownership.xml · nonDerivative · entry 1 HIRSCHHORN MARK · CIK 0001081343 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 203,586 F1 · kind: The sales reported in this Form 4 were made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on March 1, 2026. The sales were effected through and automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person. Read SEC document |
| November 05, 2024 Filed Nov 6, 2024 21:33 UTC | American Well Corp AMWL · Entity 2112 | SaleClass A Common Stock | 46,345 | $8.97 | $415,510.73 |
DisclosureSEC source: 0000950170-24-122398 · ownership.xml · nonDerivative · entry 2 HIRSCHHORN MARK · CIK 0001081343 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 214,382 F2 · kind: The sales reported in this Form 4 were made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on November 4, 2024. The sales were effected through and automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person. Read SEC document |
| November 04, 2024 Filed Nov 6, 2024 21:33 UTC | American Well Corp AMWL · Entity 2112 | GrantClass A Common Stock | 257,477 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-122398 · ownership.xml · nonDerivative · entry 1 HIRSCHHORN MARK · CIK 0001081343 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 260,727 F1 · shares: Represents a grant of restricted stock units, with 25% vesting upon the grant date and the remaining 75% vesting in substantially equal quarterly installments, with the first vest occurring on the 15-month anniversary of the grant date and subsequent vests occurring on each three-month anniversary thereafter until such restricted stock units are fully vested on the four (4) year anniversary of the grant date. Read SEC document |
| October 18, 2021 Filed Oct 20, 2021 21:31 UTC | Talkspace, Inc. TALK · Entity 22747 | GrantCommon Stock | 247,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-040799 · doc4.xml · nonDerivative · entry 1 HIRSCHHORN MARK · CIK 0001081343 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 788,967 F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Talkspace, Inc. common stock. The RSUs vest in 16 substantially equally installments on a quarterly basis, subject to the Reporting Person's continued service with the Company through each vesting date. Read SEC document |
| July 15, 2021 Filed Oct 20, 2021 21:31 UTC | Talkspace, Inc. TALK · Entity 22747 | GrantEmployee Stock Option · Derivative | 990,000 | $0.00 Strike: $5.81 | $0.00 |
DisclosureSEC source: 0000899243-21-040799 · doc4.xml · derivative · entry 2 HIRSCHHORN MARK · CIK 0001081343 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 990,000 Underlying: Common Stock · 990,000 shares Expires 2031-07-14 F2 · derivative.exercise_date: The stock option vests in 16 substantially equally installments on a quarterly basis, subject to the Reporting Person's continued service with the Company through each vesting date. Read SEC document |
| June 22, 2021 Filed Jun 25, 2021 00:02 UTC | Talkspace, Inc. TALK · Entity 22747 | GrantStock Options · Derivative | 1,730,408 | Not disclosed Strike: $1.21 | Not disclosed |
DisclosureSEC source: 0000899243-21-025801 · doc4.xml · derivative · entry 3 HIRSCHHORN MARK · CIK 0001081343 · President, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,730,408 Underlying: Common Stock · 1,730,408 shares Expires 2030-02-10 F1 · price: Pursuant to the business combination of Hudson Executive Investment Corp. and Groop Internet Platform, Inc. (d/b/a Talkspace) ("Legacy Talkspace"), each share of Legacy Talkspace outstanding common and preferred stock was automatically converted into the right to receive a combination of cash and a number shares of the Issuer's Common Stock based on a 1-to-1.1341 exchange ratio (the "Exchange Ratio") in accordance with the merger agreement governing the business combination. In addition, each outstanding Legacy Talkspace stock option was automatically converted into a corresponding stock option of the Issuer based on the Exchange Ratio and with the same terms and vesting conditions as the Legacy Talkspace equity awards. F3 · derivative.exercise_date: The stock option vested and became exercisable with respect to 25% of the underlying shares on February 10, 2021. The remainder of the stock options will vest in 36 equal monthly installments beginning on March 10, 2021. Read SEC document |
| June 22, 2021 Filed Jun 25, 2021 00:02 UTC | Talkspace, Inc. TALK · Entity 22747 | GrantStock Options · Derivative | 646,800 | Not disclosed Strike: $1.21 | Not disclosed |
DisclosureSEC source: 0000899243-21-025801 · doc4.xml · derivative · entry 2 HIRSCHHORN MARK · CIK 0001081343 · President, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 646,800 Underlying: Common Stock · 646,800 shares Expires 2030-02-10 F1 · price: Pursuant to the business combination of Hudson Executive Investment Corp. and Groop Internet Platform, Inc. (d/b/a Talkspace) ("Legacy Talkspace"), each share of Legacy Talkspace outstanding common and preferred stock was automatically converted into the right to receive a combination of cash and a number shares of the Issuer's Common Stock based on a 1-to-1.1341 exchange ratio (the "Exchange Ratio") in accordance with the merger agreement governing the business combination. In addition, each outstanding Legacy Talkspace stock option was automatically converted into a corresponding stock option of the Issuer based on the Exchange Ratio and with the same terms and vesting conditions as the Legacy Talkspace equity awards. F2 · derivative.exercise_date: The stock option is currently vested and fully exercisable. Read SEC document |
| June 22, 2021 Filed Jun 25, 2021 00:02 UTC | Talkspace, Inc. TALK · Entity 22747 | GrantCommon Stock | 541,467 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-025801 · doc4.xml · nonDerivative · entry 1 HIRSCHHORN MARK · CIK 0001081343 · President, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 541,467 F1 · price: Pursuant to the business combination of Hudson Executive Investment Corp. and Groop Internet Platform, Inc. (d/b/a Talkspace) ("Legacy Talkspace"), each share of Legacy Talkspace outstanding common and preferred stock was automatically converted into the right to receive a combination of cash and a number shares of the Issuer's Common Stock based on a 1-to-1.1341 exchange ratio (the "Exchange Ratio") in accordance with the merger agreement governing the business combination. In addition, each outstanding Legacy Talkspace stock option was automatically converted into a corresponding stock option of the Issuer based on the Exchange Ratio and with the same terms and vesting conditions as the Legacy Talkspace equity awards. Read SEC document |
| December 13, 2018 Filed Dec 17, 2018 21:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 293 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-18-013920 · edgar.xml · derivative · entry 10 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,352 Underlying: Common Stock · 293 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 13, 2018 Filed Dec 17, 2018 21:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,081 | $0.00 Strike: $12.21 | $0.00 |
DisclosureSEC source: 0001179110-18-013920 · edgar.xml · derivative · entry 9 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,194 Underlying: Common Stock · 3,081 shares Expires 2026-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 13, 2018 Filed Dec 17, 2018 21:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,284 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-18-013920 · edgar.xml · derivative · entry 8 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,692 Underlying: Common Stock · 2,284 shares Expires 2024-12-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on December 22, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 13, 2018 Filed Dec 17, 2018 21:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 684 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-18-013920 · edgar.xml · derivative · entry 7 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,151 Underlying: Common Stock · 684 shares Expires 2024-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on September 10, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 13, 2018 Filed Dec 17, 2018 21:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,001 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001179110-18-013920 · edgar.xml · derivative · entry 6 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,008 Underlying: Common Stock · 1,001 shares Expires 2023-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vests as to 25% of the shares on December 11, 2014. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 13, 2018 Filed Dec 17, 2018 21:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 293 | $22.30 | $6,533.90 |
DisclosureSEC source: 0001179110-18-013920 · edgar.xml · nonDerivative · entry 5 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2018 Filed Dec 17, 2018 21:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,081 | $12.21 | $37,619.01 |
DisclosureSEC source: 0001179110-18-013920 · edgar.xml · nonDerivative · entry 4 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,707 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2018 Filed Dec 17, 2018 21:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,284 | $6.01 | $13,726.84 |
DisclosureSEC source: 0001179110-18-013920 · edgar.xml · nonDerivative · entry 3 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,626 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2018 Filed Dec 17, 2018 21:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 684 | $6.01 | $4,110.84 |
DisclosureSEC source: 0001179110-18-013920 · edgar.xml · nonDerivative · entry 2 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,342 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2018 Filed Dec 17, 2018 21:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,001 | $1.67 | $1,671.67 |
DisclosureSEC source: 0001179110-18-013920 · edgar.xml · nonDerivative · entry 1 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,658 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2018 Filed Dec 7, 2018 21:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 10,000 | $64.96 | $649,600.00 |
DisclosureSEC source: 0001179110-18-013562 · edgar.xml · nonDerivative · entry 7 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,657 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 15, 2018. Read SEC document |
| November 20, 2018 Filed Dec 7, 2018 21:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 774 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-18-013562 · edgar.xml · derivative · entry 13 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,645 Underlying: Common Stock · 774 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| November 20, 2018 Filed Dec 7, 2018 21:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 834 | $0.00 Strike: $18.98 | $0.00 |
DisclosureSEC source: 0001179110-18-013562 · edgar.xml · derivative · entry 12 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,333 Underlying: Common Stock · 834 shares Expires 2026-09-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vests as to 25% of the shares on September 16, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| November 20, 2018 Filed Dec 7, 2018 21:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 683 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-18-013562 · edgar.xml · derivative · entry 11 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,835 Underlying: Common Stock · 683 shares Expires 2024-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vests as to 25% of the shares on September 10, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| November 20, 2018 Filed Dec 7, 2018 21:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 774 | $22.30 | $17,260.20 |
DisclosureSEC source: 0001179110-18-013562 · edgar.xml · nonDerivative · entry 6 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,657 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2018 Filed Dec 7, 2018 21:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 834 | $18.98 | $15,829.32 |
DisclosureSEC source: 0001179110-18-013562 · edgar.xml · nonDerivative · entry 5 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,883 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2018 Filed Dec 7, 2018 21:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 683 | $6.01 | $4,104.83 |
DisclosureSEC source: 0001179110-18-013562 · edgar.xml · nonDerivative · entry 4 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,049 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2018 Filed Dec 7, 2018 21:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-18-013562 · edgar.xml · derivative · entry 10 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,419 Underlying: Common Stock · 4,000 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| November 07, 2018 Filed Dec 7, 2018 21:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,081 | $0.00 Strike: $12.21 | $0.00 |
DisclosureSEC source: 0001179110-18-013562 · edgar.xml · derivative · entry 9 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,275 Underlying: Common Stock · 3,081 shares Expires 2026-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| November 07, 2018 Filed Dec 7, 2018 21:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,001 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001179110-18-013562 · edgar.xml · derivative · entry 8 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,009 Underlying: Common Stock · 1,001 shares Expires 2023-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on December 11, 2014. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| November 07, 2018 Filed Dec 7, 2018 21:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 4,000 | $22.30 | $89,200.00 |
DisclosureSEC source: 0001179110-18-013562 · edgar.xml · nonDerivative · entry 3 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,366 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2018 Filed Dec 7, 2018 21:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,081 | $12.21 | $37,619.01 |
DisclosureSEC source: 0001179110-18-013562 · edgar.xml · nonDerivative · entry 2 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,366 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2018 Filed Dec 7, 2018 21:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,001 | $1.67 | $1,671.67 |
DisclosureSEC source: 0001179110-18-013562 · edgar.xml · nonDerivative · entry 1 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,285 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2018 Filed Nov 2, 2018 21:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 10,000 | $70.13 | $701,300.00 |
DisclosureSEC source: 0001179110-18-012495 · edgar.xml · nonDerivative · entry 2 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,284 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 15, 2018. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 21:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,284 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-18-012495 · edgar.xml · derivative · entry 3 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,976 Underlying: Common Stock · 2,284 shares Expires 2024-12-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on December 22, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 21:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,284 | $6.01 | $13,726.84 |
DisclosureSEC source: 0001179110-18-012495 · edgar.xml · nonDerivative · entry 1 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,284 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 17, 2018 Filed Oct 19, 2018 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,116 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-18-012274 · edgar.xml · derivative · entry 12 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,419 Underlying: Common Stock · 2,116 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| October 17, 2018 Filed Oct 19, 2018 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 833 | $0.00 Strike: $18.98 | $0.00 |
DisclosureSEC source: 0001179110-18-012274 · edgar.xml · derivative · entry 11 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,167 Underlying: Common Stock · 833 shares Expires 2026-09-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vests as to 25% of the shares on September 16, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| October 17, 2018 Filed Oct 19, 2018 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,082 | $0.00 Strike: $12.21 | $0.00 |
DisclosureSEC source: 0001179110-18-012274 · edgar.xml · derivative · entry 10 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,356 Underlying: Common Stock · 3,082 shares Expires 2026-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| October 17, 2018 Filed Oct 19, 2018 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,284 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-18-012274 · edgar.xml · derivative · entry 9 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,260 Underlying: Common Stock · 2,284 shares Expires 2024-12-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on December 22, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| October 17, 2018 Filed Oct 19, 2018 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 684 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-18-012274 · edgar.xml · derivative · entry 8 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,518 Underlying: Common Stock · 684 shares Expires 2024-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on September 10, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| October 17, 2018 Filed Oct 19, 2018 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,001 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001179110-18-012274 · edgar.xml · derivative · entry 7 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,010 Underlying: Common Stock · 1,001 shares Expires 2023-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vests as to 25% of the shares on December 11, 2014. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| October 17, 2018 Filed Oct 19, 2018 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,116 | $22.30 | $47,186.80 |
DisclosureSEC source: 0001179110-18-012274 · edgar.xml · nonDerivative · entry 6 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 17, 2018 Filed Oct 19, 2018 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 833 | $18.98 | $15,810.34 |
DisclosureSEC source: 0001179110-18-012274 · edgar.xml · nonDerivative · entry 5 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 17, 2018 Filed Oct 19, 2018 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,082 | $12.21 | $37,631.22 |
DisclosureSEC source: 0001179110-18-012274 · edgar.xml · nonDerivative · entry 4 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,051 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 17, 2018 Filed Oct 19, 2018 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,284 | $6.01 | $13,726.84 |
DisclosureSEC source: 0001179110-18-012274 · edgar.xml · nonDerivative · entry 3 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,969 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 17, 2018 Filed Oct 19, 2018 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 684 | $6.01 | $4,110.84 |
DisclosureSEC source: 0001179110-18-012274 · edgar.xml · nonDerivative · entry 2 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,685 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.